9-109194293-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019114.5(EPB41L4B):c.2150C>T(p.Pro717Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019114.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPB41L4B | NM_019114.5 | c.2150C>T | p.Pro717Leu | missense_variant | 21/26 | ENST00000374566.8 | NP_061987.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPB41L4B | ENST00000374566.8 | c.2150C>T | p.Pro717Leu | missense_variant | 21/26 | 1 | NM_019114.5 | ENSP00000363694.3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249548Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135384
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461886Hom.: 0 Cov.: 30 AF XY: 0.0000564 AC XY: 41AN XY: 727244
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.2150C>T (p.P717L) alteration is located in exon 21 (coding exon 21) of the EPB41L4B gene. This alteration results from a C to T substitution at nucleotide position 2150, causing the proline (P) at amino acid position 717 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at